ABO blood classification and the risk of lung cancer: A meta‑analysis and trial sequential analysis

Yang,Haotian; Tan,Ziqi; Zhang,Yizhen; Sun,Jiaqi; Huang,Peng

doi:10.3892/ol.2022.13460

ABO blood classification and the risk of lung cancer: A meta‑analysis and trial sequential analysis

Authors:
- Haotian Yang
- Ziqi Tan
- Yizhen Zhang
- Jiaqi Sun
- Peng Huang
View Affiliations

Affiliations: Queen Mary School, Nanchang University, Nanchang, Jiangxi 330036, P.R. China, Center for Evidence‑Based Medicine, School of Public Health, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 12, 2022 https://doi.org/10.3892/ol.2022.13460
Article Number: 340
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with certain ABO classifications are at increased risk of certain types of malignancies. In the present study, a meta‑analysis was performed to explore the association between the ABO blood group and the risk of lung cancer from an evidence‑based medical perspective. The PubMed, Embase, Web of Science, Medline, China National Knowledge Infrastructure, Google Scholar, Science Direct and Wanfang databases were searched for relevant papers. Review Manger 5.4 was used to analyze the association between the ABO blood group and the risk of lung cancer. Trial Sequential Analysis (TSA) was used to determine whether the sample size of the meta‑analysis was sufficient. A total of 29 studies were included in this paper. The results of the case‑controlled studies showed that the proportion of patients with blood type A in patients with lung cancer was significantly higher than that in healthy individuals [odds ratio (OR), 1.10; 95% confidence interval (CI), 1.02‑1.19]. Based on the subgroup analysis, type A blood showed heterogeneity in ethnicity and source of control (social or hospital). Additionally, type O blood was determined to be a protective factor for lung cancer in Caucasians (OR, 0.92; 95% CI, 0.85‑0.99). TSA results suggested that there were sufficient participants in the case‑controlled studies. Overall, the results of the cohort studies showed that the risk of lung cancer and blood type were weakly associated, and that the difference was not statistically significant. The case‑controlled studies suggested that blood type A was associated with a higher risk of lung cancer. In addition, the analysis confirmed that Caucasians with type O blood had a lower risk of lung cancer. However, prospective cohort studies have not been able to draw this conclusion. Different experimental designs may have had a notable influence on the results obtained.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
2	Wu X, Zhao H, Suk R and Christiani DC: Genetic susceptibility to tobacco-related cancer. Oncogene. 23:6500–6523. 2004. View Article : Google Scholar : PubMed/NCBI
3	Vachani A, Sequist LV and Spira A: AJRCCM: 100-Year anniversary. The shifting landscape for lung cancer: Past, present, and future. Am J Respir Crit Care Med. 195:1150–1160. 2017. View Article : Google Scholar : PubMed/NCBI
4	Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B and Aggarwal BB: Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 25:2097–2116. 2008. View Article : Google Scholar : PubMed/NCBI
5	Aird I, Bentall HH and Roberts JA: A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1:799–801. 1953. View Article : Google Scholar : PubMed/NCBI
6	Hems G: Epidemiological characteristics of breast cancer in middle and late age. Br J Cancer. 24:226–234. 1970. View Article : Google Scholar : PubMed/NCBI
7	Vioque J and Walker AM: Pancreatic cancer and ABO blood types: A study of cases and controls. Med Clin (Barc). 96:761–764. 1991.(In Spanish). PubMed/NCBI
8	Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, Lauretani F, Murray A, Gibbs JR, Paolisso G, et al: A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 4:e10000722008. View Article : Google Scholar : PubMed/NCBI
9	Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A, et al: Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 19:1863–1872. 2010. View Article : Google Scholar : PubMed/NCBI
10	Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, Shen E, Mirea L, Bharaj B, Sun L, et al: Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol. 29:1958–1967. 2009. View Article : Google Scholar : PubMed/NCBI
11	Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, Girman CJ, Laurie CC, Mirel DB, Hunter DJ, et al: Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet. 19:1856–1862. 2010. View Article : Google Scholar : PubMed/NCBI
12	Vowden P, Lowe AD, Lennox ES and Bleehen NM: The expression of ABH and Y blood group antigens in benign and malignant breast tissue: The preservation of the H and Y antigens in malignant epithelium. Br J Cancer. 53:313–319. 1986. View Article : Google Scholar : PubMed/NCBI
13	Strauchen JA, Bergman SM and Hanson TA: Expression of A and B tissue isoantigens in benign and malignant lesions of the breast. Cancer. 45:2149–2155. 1980. View Article : Google Scholar : PubMed/NCBI
14	Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B and Clément M: ABH and Lewis histo-blood group antigens in cancer. APMIS. 109:9–31. 2001. View Article : Google Scholar : PubMed/NCBI
15	Urun Y, Utkan G, Cangir AK, Oksuzoglu OB, Ozdemir N, Oztuna DG, Kocaman G, Coşkun HŞ, Kaplan MA, Yuksel C, et al: Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey. Asian Pac J Cancer Prev. 14:2801–2803. 2013. View Article : Google Scholar : PubMed/NCBI
16	Peng M, Yu S, Wang J and Wang D: Relationship between ABO blood group and risk of 8 kinds of malignant tumors. Chin J Health Inspection. 24:811–813+823. 2014.(In Chinese).
17	Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M and Tugwell P: The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 18:727–734. 2014.https://www.ohri.ca/programs/clinical_epidemiology/oxford.aspMarch 2–2022
18	Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G and Gluud C: User Manual for Trial Sequential Analysis (TSA). 2nd edition. Copenhagen: Copenhagen Trial Unit; pp. 1–119. 2017
19	Xu A, He X, Wang W, Tang Y and Ping W: Relationship between ABO blood group and gastric cancer, liver cancer and lung cancer. J Clin Mil Med. 722–723. 2006.(In Chinese).
20	Oguz A, Unal D, Tasdemir A, Karahan S, Aykas F, Mutlu H, Cihan YB and Kanbay M: Lack of any association between blood groups and lung cancer, independent of histology. Asian Pac J Cancer Prev. 14:453–456. 2013. View Article : Google Scholar : PubMed/NCBI
21	Li B, Tan B, Chen C, Zhao L and Qin L: Association between the ABO blood group and risk of common cancers. J Evid Based Med. 7:79–83. 2014. View Article : Google Scholar : PubMed/NCBI
22	Sun B and Zheng Y: ABO blood group typing in lung cancer patients. J Clin Pulmonology. 2:302001.(In Chinese).
23	Yang C, Zhang R, Zhou S and Wang Q: Discussion on the relationship between ABO blood group and lung cancer, liver cancer and gastric cancer. Clin Transfus Lab. 1:11–12. 2000.(In Chinese).
24	Li J, Hu J and Wang M: The correlation between esophageal cancer, lung cancer and ABO blood group. Chin J Blood Transfus. 1:45–46. 1995.(In Chinese).
25	Wang H and Liang X: Relationship between ABO blood group and 10 kinds of malignant tumors of Han nationality in Guangxi. Med Lit. 5:643–644. 2000.(In Chinese).
26	Gao H, Zhao L, Wu S, Wang D, Li Y and Heyun S: Relationship between malignant tumor and ABO blood group. Chin J Prim Med. 4:41–42. 1998.(In Chinese).
27	Xiao H, Xiang S, Shan Z and Bin X: Relationship between ABO blood group and different pathological types of lung cancer in southern Sichuan. Chin J Mod Med. 31:98–102. 2021.(In Chinese).
28	Huang JY, Wang R, Gao YT and Yuan JM: ABO blood type and the risk of cancer-findings from the Shanghai cohort study. PLoS One. 12:e01842952017. View Article : Google Scholar : PubMed/NCBI
29	Feng J and Ying X: Correlation analysis between ABO blood group and lung cancer in Zhejiang Han people. Harbin Med. 33:96–97. 2013.(In Chinese).
30	Chen L, Heng C, Shen W and Xiao X: Correlation analysis between ABO blood group and malignant tumor. Chin J Oncol. 3:131–133. 2004.(In Chinese).
31	Hsiao LT, Liu NJ, You SL and Hwang LC: ABO blood group and the risk of cancer among middle-aged people in Taiwan. Asia Pac J Clin Oncol. 11:e31–e36. 2015. View Article : Google Scholar : PubMed/NCBI
32	Tang L, Ren Z, Zhou X, Su Z and Zhuang Z: ABO blood group and its interaction with smoking and lung cancer susceptibility. Chronic Dis Prev Control China. 2:70–71. 2001.(In Chinese).
33	McConnell RB, Clarke CA and Downton F: Blood groups in carcinoma of the lung. Br Med J. 2:323–325. 1954. View Article : Google Scholar : PubMed/NCBI
34	Zhao P, Wu Q and Wang S: Lung cancer and ABO blood group relationship. Chin J Eugenics Genet. 59–60. 1993.(In Chinese).
35	Rennie HM and Haber RW: Blood groups and carcinoma of the lung. Med J Aust. 48:61–62. 1961. View Article : Google Scholar : PubMed/NCBI
36	Jiang T and Wang Z: ABO blood group distribution in 288 patients with lung cancer. J Chongqing Med Univ. 220–221. 1989.(In Chinese).
37	Pan T, Zheng Z, Li J, Chen T, Wei X, Hu M and Liu L: ABO blood group and lung cancer in Hubei province and literature review. Sixth National Thoracic and Cardiovascular Surgery Conference; Beijing, China: pp. 22006, (In Chinese). PubMed/NCBI
38	Sun W, Wen CP, Lin J, Wen C, Pu X, Huang M, Tsai MK, Tsao CK, Wu X and Chow WH: ABO blood types and cancer risk-a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiol. 39:150–156. 2015. View Article : Google Scholar : PubMed/NCBI
39	Liu X, Chen X, Yang J and Guo R: Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer. Oncol Lett. 14:3787–3794. 2017. View Article : Google Scholar : PubMed/NCBI
40	Zhang YW: Preliminary analysis of ABO blood group distribution in cancer patients. J Hubei Med Coll. 369–371. 1990.(In Chinese).
41	Jin YY, Wang ZY and Cheng CH: Relationship between ABO blood group and 3 common cancers. J Luoyang Med Coll. 3:2482000.(In Chinese).
42	Guo ZH: Lung cancer and ABO blood group. Chin J Mod Med. 1:61–63. 2001.(In Chinese).
43	Liu Z, Qiao Z and Huang P: Association between ABO blood group and lung cancer. Mod Med Health. 14:2134–2135. 2006.(In Chinese).
44	Cai Z, Fang W, Qin J, Chen S and Lai K: Correlation between ABO blood group and malignant tumors in Guangzhou area. J Appl Med Technol. 21:3727–3729. 2006.(In Chinese).
45	Wang Z: ABO blood group distribution analysis of lung cancer patients. Shaanxi Med Lab. 242–243. 1993.(In Chinese).
46	Landsteiner K: ZTo know the antifermentative, lytic and agglutinative effects of blood serum and lymph. Centr Bakt Orig. 27:357–362. 1900.(In German).
47	Landsteiner K: About agglutination symptoms of normal human blood. Wien Klin Wochschr. 14:1132–1134. 1901.(In German).
48	Wagner FF, Flegel WA, Bittner R and Döscher A: Molecular typing for blood group antigens within 40 min by direct polymerase chain reaction from plasma or serum. Br J Haematol. 176:814–821. 2017. View Article : Google Scholar : PubMed/NCBI
49	Tang Z: Introduction to modern oncology. Med Res Lett. 242001.
50	Hakomori S: Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer. Biochim Biophys Acta. 1473:247–266. 1999. View Article : Google Scholar : PubMed/NCBI
51	Zhang S, Zhang HS, Cordon-Cardo C, Reuter VE, Singhal AK, Lloyd KO and Livingston PO: Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int J Cancer. 73:50–56. 1997. View Article : Google Scholar : PubMed/NCBI
52	Marionneau S, Le Moullac-Vaidye B and Le Pendu J: Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells. Glycobiology. 12:851–856. 2002. View Article : Google Scholar : PubMed/NCBI
53	Sequist LV and Lynch TJ: EGFR tyrosine kinase inhibitors in lung cancer: An evolving story. Annu Rev Med. 59:429–442. 2008. View Article : Google Scholar : PubMed/NCBI